Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current Assets
Cash and cash equivalents	$ 7,320	$ 23,511
Accounts receivable, net	128,793	78,181
Unbilled receivables	22,133	20,834
Inventory	89,878	55,977
Other current assets	9,762	9,849
Total Current Assets	257,886	188,352
Property, plant and equipment, net	53,302	28,222
Goodwill	69,941	69,941
Other intangible assets, net	33,499	41,083
Deferred tax assets	438,027	454,160
Right-of-use operating lease assets	46,044	1,786
Other assets	5,402	9,536
Total Assets	904,101	793,080
Current Liabilities
Accounts payable	64,875	20,032
Accrued expenses and other	22,215	12,541
Warranty liability—current portion	3,202	29,602
Deferred revenue	37,031	18,737
Total Current Liabilities	127,323	80,912
Revolving line of credit	136,750	141,750
Right-of-use operating lease liabilities, less current portion	38,661	1,235
Warranty liability, less current portion	403	11,392
Other long-term liabilities	991	991
Total Liabilities	304,128	236,280
Commitments and Contingencies (Note 15)
Stockholders’ Equity
Preferred stock, $0.00001 par value - 5,000,000 shares authorized; none issued and outstanding as of December 31, 2025 and 2024	0	0
Additional paid-in capital	493,090	483,550
Treasury stock, at cost, 3,908,387 shares as of December 31, 2025 and 2024, respectively	(25,272)	(25,331)
Retained Earnings	132,153	98,579
Total Stockholders' Equity	599,973	556,800
Total Liabilities and Stockholders’ Equity	904,101	793,080
Class A Common Stock
Stockholders’ Equity
Class A common stock, $0.00001 par value - 1,000,000,000 shares authorized; 171,358,711 and 170,670,779 shares issued, 167,450,324 and 166,762,392 outstanding as of December 31, 2025 and 2024, respectively	$ 2	$ 2